C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Ar...

Por Nirmal K. Banda, Stephen Tomlinson, Robert I. Scheinman, Nhu Ho, Nhu Ho, Joseline Ramos Ramirez, Gaurav Mehta, Guankui Wang, Vivian Pham Vu, Dmitri Simberg, Liudmila Kulik, V. Michael Holers
Publicado em 2020-10-01